- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02465164
Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin
April 26, 2023 updated by: Justin Bruner, Henry Ford Health System
The purpose of this study is to compare if using a Cook Cervical Ripening Balloon in conjunction with low dose oxytocin is more effective at shortening labor induction times than the Cook Cervical Ripening Balloon alone.
After obtaining consent, patients will be randomly divided into a Balloon with oxytocin or Balloon only group.
The Balloon will be placed by either Resident or Attending Physicians and left in place for 12 hours (protocol) in both groups or until it falls out.
After either 12 hours or the Balloon falls out, oxytocin will be used for the remainder of the induction per current hospital protocol.
Time to delivery, mode of delivery, average number of hours Balloon remained in place, non-reassuring fetal heart tracings, adverse outcomes (ie fetal malpresentation, postpartum hemorrhage) will be recorded.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 38 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- singleton pregnancy
- reassuring fetal status at time of presentation
- Bishop Score <6
Exclusion Criteria:
- Closed cervix
- Breech presentation
- Multiple gestations
- Recent vaginal bleeding
- Placenta previa
- non reassuring fetal status
- Active genital herpes infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Cook catheter
Control
|
|
Active Comparator: Cook catheter plus low dose oxytocin
Test group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to Delivery (in Hours)
Time Frame: Up to 60 hours
|
Cook Only group Cook + Pitocin group N Mean (hrs) (SD) 16 27.9
(9.6) 10 23 14.6)
|
Up to 60 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2015
Primary Completion (Actual)
July 30, 2016
Study Completion (Actual)
July 30, 2016
Study Registration Dates
First Submitted
June 3, 2015
First Submitted That Met QC Criteria
June 4, 2015
First Posted (Estimate)
June 8, 2015
Study Record Updates
Last Update Posted (Actual)
May 22, 2023
Last Update Submitted That Met QC Criteria
April 26, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HFM 2900
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Ripening
-
Western Galilee Hospital-NahariyaRecruiting
-
Stanford UniversityCompletedCervical RipeningUnited States
-
Universidad de la RepublicaCompleted
-
Zekai Tahir Burak Women's Health Research and Education...UnknownCervical RipeningTurkey
-
Ferring PharmaceuticalsCompleted
-
University Hospital, Strasbourg, FranceCompletedCervical RipeningFrance
-
Ferring PharmaceuticalsCompleted
-
Planned Parenthood League of MassachusettsSociety of Family PlanningCompleted
-
Cairo UniversityUnknownCervical RipeningEgypt
-
Wenzhou Medical UniversityUnknown
Clinical Trials on Oxytocin
-
Hillel Yaffe Medical CenterUnknownCervix; Insufficient Dilatation in LaborIsrael
-
University of NebraskaNational Institute of Mental Health (NIMH)Terminated
-
University of Electronic Science and Technology...Completed
-
GlaxoSmithKlineCompletedPostpartum HemorrhageUnited Kingdom
-
University of Electronic Science and Technology...Recruiting
-
GlaxoSmithKlineMonash University; InVentiv CliniqueTerminatedPostpartum HemorrhageAustralia, United Kingdom
-
University Hospital, ToulouseCompleted
-
OptiNose ASUniversity of OsloCompletedHealthy Male AdultsNorway
-
Washington University School of MedicineUniversity of MichiganRecruiting
-
University of NebraskaNot yet recruiting